Abstract:Background: In the heart, acute injury induces a fibrotic healing response that generates collagen-rich scarring that is at first protective but if inappropriately sustained can worsen heart disease. The fibrotic process is initiated by cytokines, neuroendocrine effectors, and mechanical strain that promote resident fibroblast differentiation into contractile and extracellular matrix–producing myofibroblasts. The mitogen-activated protein kinase p38α ( Mapk14 gene) is known to influence the cardiac injury response, but its direct role in orchestrating programmed fibroblast differentiation and fibrosis in vivo is unknown. Methods: A conditional Mapk14 allele was used to delete the p38α encoding gene specifically in cardiac fibroblasts or myofibroblasts with 2 different tamoxifen-inducible Cre recombinase–expressing gene–targeted mouse lines. Mice were subjected to ischemic injury or chronic neurohumoral stimulation and monitored for survival, cardiac function, and fibrotic remodeling. Antithetically, mice with fibroblast-specific transgenic overexpression of activated mitogen-activated protein kinase kinase 6, a direct inducer of p38, were generated to investigate whether this pathway can directly drive myofibroblast formation and the cardiac fibrotic response. Results: In mice, loss of Mapk14 blocked cardiac fibroblast differentiation into myofibroblasts and ensuing fibrosis in response to ischemic injury or chronic neurohumoral stimulation. A similar inhibition of myofibroblast formation and healing was also observed in a dermal wounding model with deletion of Mapk14 . Transgenic mice with fibroblast-specific activation of mitogen-activated protein kinase kinase 6–p38 developed interstitial and perivascular fibrosis in the heart, lung, and kidney as a result of enhanced myofibroblast numbers. Mechanistic experiments show that p38 transduces cytokine and mechanical signals into myofibroblast differentiation through the transcription factor serum response factor and the signaling effector calcineurin. Conclusions: These findings suggest that signals from diverse modes of injury converge on p38α mitogen-activated protein kinase within the fibroblast to program the fibrotic response and myofibroblast formation in vivo, suggesting a novel therapeutic approach with p38 inhibitors for future clinical application.

P42/p44 ERK Modulates TGF-β1-mediated Phosphorylation and Translocation in Cardiac Myofibroblasts

Role of Extracellular Signal-Regulated Kinase, P38 Kinase, and Activator Protein-1 in Transforming Growth Factor- Β 1–induced Alpha Smooth Muscle Actin Expression in Human Fetal Lung Fibroblasts in Vitro

The Linker Region of Smad2 Mediates Tgf-Beta-Dependent Erk2-Induced Collagen Synthesis

Tyrosine phosphorylation of the LDL receptor-related protein (LRP) and activation of the ERK pathway are required for connective tissue growth factor to potentiate myofibroblast differentiation.

Role of Cross-Talk Between the Smad2 and Mapk Pathways in Tgf-Beta 1-Induced Collagen Iv Expression in Mesangial Cells

Transforming Growth Factor-β Receptor Type I-dependent Fibrogenic Gene Program is Mediated Via Activation of Smad1 and ERK1/2 Pathways

PDGF-CC induced rat myocardial fibrosis is mediated by ERK 1 / 2 signaling pathway and potential mechanism

TSC-22 Promotes Transforming Growth Factor Β-Mediated Cardiac Myofibroblast Differentiation by Antagonizing Smad7 Activity

Fibroblast-Specific Genetic Manipulation of p38 Mitogen-Activated Protein Kinase In Vivo Reveals Its Central Regulatory Role in Fibrosis

P2Y1 Receptor Agonist Attenuates Cardiac Fibroblasts Activation Triggered by TGF-β1

MAPKs signaling pathway is involved in transdifferentiation of airway epithelial cells into myofibroblasts induced by transforming growth factor-β1 in vitro

[Connective Tissue Growth Factor Promotes the Proliferation of Myofibroblast Through Erk-1/2 Signaling Pathway].

Crosstalk between Smad2/3 and specific isoforms of ERK in TGF-β1-induced TIMP-3 expression in rat chondrocytes.

Pivotal Role of TGF-β/Smad Signaling in Cardiac Fibrosis: Non-coding RNAs as Effectual Players

Transforming growth factor-beta receptor type 1 (TGFbetaRI) kinase activity but not p38 activation is required for TGFbetaRI-induced myofibroblast differentiation and profibrotic gene expression.

Role of PDGFR-β/PI3K/AKT Signaling Pathway in PDGF-BB Induced Myocardial Fibrosis in Rats.

P2Y1 Receptor Agonist Attenuates Cardiac Fibroblasts Activation Triggered by TGF-1

ERK1/2 signaling pathway mediates PDGF-CC-induced rat cardiac fibrosis and its mechanism

A Crosstalk Between the Smad and JNK Signaling in the TGF-β-induced Epithelial-Mesenchymal Transition in Rat Peritoneal Mesothelial Cells.

P38 Mitogen-Activated Protein Kinase Affects Transforming Growth Factor-β/Smad Signaling in Human Dental Pulp Cells

Smad4 and ERK2 Stimulated by Transforming Growth Factor Beta1 in Rhabdomyosarcoma.